29-Oct-2026 17:22:21
NATCO PHARMA : BOARD MEETING ON 13 NOVEMBER TO CONSIDER Q2 RESULTS, SECOND INTERIM DIVIDEND
Trading window shut from 30 October to 15 November 2026, reopens 16 November 2026.
Latest market headlines for NATCOPHARM on Terminal.
29-Oct-2026 17:22:21
Trading window shut from 30 October to 15 November 2026, reopens 16 November 2026.
23-Oct-2026 21:07:02
• Fund Raising Committee on October 23, 2026 approved allotment of 1,70,58,082 equity shares at ₹750 each (premium of ₹748) • Allotment value works out to ~₹1,…
22-Oct-2026 13:24:25
• Rights issue of equity shares of face value ₹2 each at ₹750 per share • Issue size up to ₹1,279.4 Cr (₹12,794 million) • Issue opened on 12 October 2026 and…
19-Oct-2026 14:20:23
• U.S. subsidiary NATCO Pharma USA LLC launches generic version of Paraplatin • Launch in manufacturing collaboration with Chennai-based Teyro Labs Pvt Ltd • P…
14-Oct-2026 20:54:24
ASK INVESTMENT MANAGERS LIMITED, 1,03,147 SHARES SOLD 🔴 (0.06% EQUITY) AT ₹27.00 ... NIPPON INDIA MUTUAL FUND, 2,32,343 SHARES BOUGHT 🟢 (0.13% EQUITY) AT ₹27…
13-Oct-2026 19:37:58
VENKAIAH CHOWDARY NANNAPANENI, 2,67,656 SHARES SOLD 🔴 (0.15% EQUITY) AT ₹34.42 ... NEELIMA SITA NANNAPANENI, 2,37,963 SHARES BOUGHT 🟢 (0.13% EQUITY) AT ₹35.5…
12-Oct-2026 20:08:30
VENKATA SATYA SWATHI KANTAMANI, 3,33,333 SHARES SOLD 🔴 (0.19% EQUITY) AT ₹32.52 ... NATSOFT INFORMATION SYSTEMS PRIVATE LIMITED, 12,00,000 SHARES SOLD 🔴 (0.6…
28-Sept-2026 20:54:06
• Fund-raising committee approved the letter of offer for the rights issue. • Company obtained ISIN: INE987B20018 for credit of rights entitlements. • The meet…
28-Sept-2026 14:57:40
• The investment comprises US$ 13.70 million by NATCO Pharma (Canada) Inc. and US$ 3 million by NATCO Pharma USA LLC through convertible promissory notes. • eG…
25-Sept-2026 11:18:57
• Rights issue size of ₹12,793.56 Cr • Issue price fixed at ₹750 per share • Record date Oct 1, 2026; rights issue period Oct 12-22, 2026 • Entitlement ratio:…
22-Sept-2026 17:59:03
NATCO PHARMA : BOARD MEETING ON SEP 25 TO DECIDE ON RIGHTS ISSUE
21-Sept-2026 22:45:57
• Company received in-principle approval from NSE and BSE for rights issue of fully paid-up equity shares. • Approval received on September 21, 2026. • Copies…
09-Sept-2026 17:50:31
• NATCO to issue rights equity shares of face value ₹2 each at an issue price of ₹[●] per share. • The issue size aggregates up to ₹13,000 million. • Funds to…
25-Aug-2026 12:19:37
• Natco Pharma Limited is investing US$ 14 million in eGenesis, Inc. • Investment is being made through wholly owned subsidiaries NATCO Pharma (Canada) Inc. (U…
18-Jul-2026 16:40:25
NATCO PHARMA : US FDA GRANTS TENTATIVE APPROVAL FOR OLAPARIB TABLETS